MagBio Genomics

Executive Summary

MagBio Genomics is a leading provider of magnetic bead-based kits for nucleic acid isolation, including DNA, cfDNA, and RNA extraction. Founded in 2015 and headquartered in Gaithersburg, Maryland, the company serves the diagnostics and genomics research sectors. Its proprietary magnetic bead technology enables efficient, high-purity nucleic acid purification, a critical step in molecular diagnostics and genomic analysis. While the company is private and financial details are limited, its focus on a key enabling technology positions it well in the growing genomics tools market. MagBio's products are used in research and clinical applications, and the company may benefit from increasing demand for liquid biopsy and precision medicine workflows.

Upcoming Catalysts (preview)

• Q3 2026Launch of new cfDNA extraction kit for liquid biopsy70% success
• TBDFDA 510(k) clearance for a nucleic acid isolation kit used in diagnostic assays50% success
• Q4 2026Strategic partnership with a major diagnostic or pharmaceutical company40% success